Dosing intervals

The interval between the first and second doses of the Cominarty® (Pfizer) vaccine has now been reduced from 42 days to 21 days, AND you can receive a booster dose 90 days (three months) after receiving the second dose of the vaccine (reduced from 180 days).

Introduction of heterologous (different) booster doses

You may now receive heterologous booster doses – in other words, booster doses of a different vaccine to that which was administered to you originally.

• Individuals older than 18 years who’ve received one dose of the COVID-19 vaccine Janssen® (J&J), may receive a booster dose of the same vaccine OR a booster dose of Cominarty® vaccine after an interval of two months (60 days).

• Individuals over the age of 18 who’ve received two doses of the Cominarty® (Pfizer) vaccine, may receive a booster dose of the same vaccine OR a booster dose of the COVID-19 vaccine Janssen®, 90 days (three months) after receiving the second of the two doses of the Cominarty® vaccine.

The decision regarding which vaccine to administer as a booster should be guided by vaccine availability. If both vaccines are available, homologous boosting should be preferred, unless the vaccinee requests to receive a heterologous booster dose, or has a history of experiencing an adverse event following immu-

nisation. Please remember that all adverse events following immunisation must be reported.

Vaccination schedules are now as follows:

OR

All booster doses must be recorded on the EVDS.

The EVDS is currently being updated so that individuals who did not receive their primary COVID vaccinations in South Africa, but are eligible to receive a booster dose, can be registered on the EVDS and receive the booster dose.

Once the functionality is available on the EVDS, the vaccination of such individuals should proceed. We will keep you updated.

Dosing intervals

The interval between the first and second doses of the Cominarty® (Pfizer) vaccine has now been reduced from 42 days to 21 days, AND you can receive a booster dose 90 days (three months) after receiving the second dose of the vaccine (reduced from 180 days).

Introduction of heterologous (different) booster doses

You may now receive heterologous booster doses – in other words, booster doses of a different vaccine to that which was administered to you originally.

• Individuals older than 18 years who’ve received one dose of the COVID-19 vaccine Janssen® (J&J), may receive a booster dose of the same vaccine OR a booster dose of Cominarty® vaccine after an interval of two months (60 days).

• Individuals over the age of 18 who’ve received two doses of the Cominarty® (Pfizer) vaccine, may receive a booster dose of the same vaccine OR a booster dose of the COVID-19 vaccine Janssen®, 90 days (three months) after receiving the second of the two doses of the Cominarty® vaccine.

The decision regarding which vaccine to administer as a booster should be guided by vaccine availability. If both vaccines are available, homologous boosting should be preferred, unless the vaccinee requests to receive a heterologous booster dose, or has a history of experiencing an adverse event following immu-

nisation. Please remember that all adverse events following immunisation must be reported.

Vaccination schedules are now as follows:

OR

All booster doses must be recorded on the EVDS.

The EVDS is currently being updated so that individuals who did not receive their primary COVID vaccinations in South Africa, but are eligible to receive a booster dose, can be registered on the EVDS and receive the booster dose.

Once the functionality is available on the EVDS, the vaccination of such individuals should proceed. We will keep you updated.